"Somos el sanatorio polivalente más avanzado de la región."

During the past decade, Sanatorio Parque conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 19 clinical trials were completed, i.e. on average, 52.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio Parque" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Parque" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Parque" are "Pulmonary Arterial Hypertension" (4 trials), "Metastatic Breast Cancer" (3 trials), "Prostatic Neoplasms" (3 trials), "Breast Neoplasms" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Sanatorio Parque" in a lesser frequency.

Most popular intervention types in "Sanatorio Parque" are "Drug" (43 trials), "Biological" (8 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Prednisone" (5 trials), "Abemaciclib" (3 trials), "Atezolizumab" (3 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Parque" are 41 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sanatorio Parque". undefined are not yet recruiting, 6 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in Sanatorio Parque, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Parque, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".